Cathay Capital

About Cathay Capital

Cathay Capital is a cross-border private equity and venture firm with €5.5 billion of assets under management as of December 2024, headquartered in Paris with offices in Shanghai, Beijing, Shenzhen, New York and San Francisco. Founded in 2007, the firm specialises in cross-border investments helping European and US companies expand internationally with a particular focus on the China corridor, plus Chinese and Asian companies expanding into Europe and North America. The unique cross-border mandate distinguishes Cathay from regional-focused peers.

Investment thesis

Cathay deploys capital across complementary strategies including mid-market LBO (Cathay Capital PE) and late-stage technology venture (Cathay Innovation), with sectors spanning Consumer, Industrials, Software, Fintech and Healthcare. The platform's cross-border value-add focuses on supporting portfolio companies through international expansion, sourcing partnerships and operational capabilities across the three core regions of France-China-US. Equity ticket sizes vary by strategy from venture-stage early commitments through to mid-cap LBO majority equity positions of €20 million to €150 million.

Recent activity

Recent realised exits include TransCure bioServices (healthcare, 2026), DIOT-SIACI (fintech, 2025), Saagie (software, 2025), Artefact (software, 2024), Biose Industrie (healthcare, 2024) and Datawords (software, 2024), reflecting active distribution across the cross-border franchise. The platform tracks 15 funds, 167 active portfolio companies and 68 realised exits across multiple investment cycles. Detailed buyer names and multiple data available on Pro at €49/month.